Independent Insights, a Health Mart Podcast brings together independent pharmacy owners and other community pharmacy experts to inspire all pharmacy team members to not just survive, but thrive in building practices that cater to the needs of local communities. Plug in to hear ways to innovate patient care services and strengthen the overall health of your pharmacy business.
Plus, sharpen your clinical skills with GameChangers Clinical Conversations - a weekly pharmacotherapy podcast featuring the latest game-changing advances in patient care. New episodes arrive every Monday and are available for CE credit. Check the show notes for instructions on how to redeem your credit.
Happy listening!
This week's GameChangers explores the transformative impact of continuous glucose monitors (CGMs) on diabetes care. Discover the latest advancements in CGM technology, current ADA recommendations, an…
This week's GameChangers is a conversation about managing symptoms and age-related health effects through perimenopause, menopause, and post-menopause. Help patients through this time with evidence-b…
In this week's episode of GameChangers Podcast, we delve into the groundbreaking reclassification of marijuana to Schedule III. We discuss impacts on the legal landscape, medical research, pharmacoge…
Join us as we explore new trial data examining Paxlovid's effectiveness in high-risk, vaccinated patients.
The GameChanger
Significantly high-risk patients are still at risk from active Covid-19 infec…
New guidelines suggest that for most asthma patients a single inhaler strategy with both an ICS and a quick onset LABA can be used for maintenance and rescue therapy. This has been shown to improve s…
40% of people experience vertigo in their lifetime. These simple questions help us know what's causing it and how to provide relief to patients through medications or triaging to the appropriate prov…
Join us this episode as we discuss new recommendations from the American Dental Association on acute pain management.
The GameChanger
Dosing acetaminophen and ibuprofen where they peak at the same tim…
Shortages, access, and cost have led to compounding GLP1s, which has created confusion and misinformation for patients and healthcare providers. Join us as we discuss this practice and delve into wha…
This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused…
This episode discusses quality and value in healthcare and how the BPCI program, designed to lower costs and enhance care quality, particularly in the post-acute phase, did not demonstrate notable po…